Medicines Intelligence CRE
@medintelcre
We’re an NHMRC-funded national research collaboration delivering real-world evidence on the quality use of medicines in Australia.
ID: 1392345617066729477
12-05-2021 05:08:52
438 Tweet
200 Followers
187 Following
Long-term prescription opioid use after hospital declining: study. UNSW Sydney medical researchers from Medicines Intelligence CRE and NDARC, UNSW have shed light on post-hospital prescription opioid use. unsw.edu.au/newsroom/news/…
Clinical guidelines do not recommend use of quit-smoking meds varenicline and bupropion during pregnancy due to lack of evidence on safety. This study by Medicines Intelligence CRE and NDARC, UNSW researchers is reassuring that usage is low. Next step is to fill the evidence gap on safety!
Excited to be speaking at the Hypertension Winter School this Friday I'll be presenting on the power of pharmacoepidemiology to monitor population-wide adherence to antihypertensive medications Hypertension Australia Monash University School of Clinical Sciences Medicines Intelligence CRE Heart Foundation Stroke Foundation
Excited to be attending the Medicines Intelligence CRE Research Symposium and Policy Forum 👏 A full day of presentations on pharmacoepi advances, consumer involvement and impact #MICRE2024 Sallie Pearson Jack Janetzki NHMRC
And we are off! The 2024 MI-CRE Annual Research Symposium and Policy Forum kicks off with our theme of 'Bringing it home'. Sallie Pearson Jack Janetzki Symposium Co-Chairs.
Our paper on the MedIntel Data Platform has now been published in PDS: onlinelibrary.wiley.com/doi/10.1002/pd…. To quote the National Data Commissioner in DataPoints, it's a "good use of public data"! #BigData #Pharmacoepidemiology Sallie Pearson
Our Director Sallie Pearson was thrilled to be a part of this great new conference and discussed the value of using real-world evidence in health technology assessment.